- Home
- MNDO vs ENLV Comparison
MNDO vs ENLV Comparison
Compare MNDO & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- ENLV
- Stock Information
- Founded
- MNDO 1995
- ENLV 2005
- Country
- MNDO Israel
- ENLV Israel
- Employees
- MNDO N/A
- ENLV N/A
- Industry
- MNDO EDP Services
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- ENLV Health Care
- Exchange
- MNDO Nasdaq
- ENLV Nasdaq
- Market Cap
- MNDO 24.2M
- ENLV 23.7M
- IPO Year
- MNDO 2000
- ENLV 1995
- Fundamental
- Price
- MNDO $1.20
- ENLV $1.05
- Analyst Decision
- MNDO
- ENLV Strong Buy
- Analyst Count
- MNDO 0
- ENLV 2
- Target Price
- MNDO N/A
- ENLV $10.00
- AVG Volume (30 Days)
- MNDO 59.4K
- ENLV 1.2M
- Earning Date
- MNDO 08-11-2025
- ENLV 08-29-2025
- Dividend Yield
- MNDO 18.18%
- ENLV N/A
- EPS Growth
- MNDO N/A
- ENLV N/A
- EPS
- MNDO 0.15
- ENLV N/A
- Revenue
- MNDO $20,155,000.00
- ENLV N/A
- Revenue This Year
- MNDO N/A
- ENLV N/A
- Revenue Next Year
- MNDO N/A
- ENLV N/A
- P/E Ratio
- MNDO $8.00
- ENLV N/A
- Revenue Growth
- MNDO N/A
- ENLV N/A
- 52 Week Low
- MNDO $1.02
- ENLV $0.81
- 52 Week High
- MNDO $2.13
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- MNDO 43.61
- ENLV 40.57
- Support Level
- MNDO $1.10
- ENLV $0.98
- Resistance Level
- MNDO $1.20
- ENLV $1.13
- Average True Range (ATR)
- MNDO 0.06
- ENLV 0.16
- MACD
- MNDO 0.01
- ENLV -0.04
- Stochastic Oscillator
- MNDO 72.00
- ENLV 7.14
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.